Abstract:The Provirus Integration sites for Moloney murine leukemia virus (Pim) kinases are a highly conserved family of serine/threonine kinases. The Pim kinase family is composed of three different isoforms, Pim1, Pim2, and Pim3, which have been studied extensively in tumorigenesis and as a potential therapeutic target in various cancers. We previously reported an unexpected role of Pim2 in negatively regulates T-cell responses to alloantigen and tumor (JCI, 2015, PMID: 29781812). However, the mechanisms by which Pim2 modulates T-cell responses remain largely undefined. In the current study, using genetic Pim2-deficient mouse, we demonstrated a key role of Pim2 in regulating T-cell hemostatic and anti-tumor responses in aging, hematopoietic cell transplantation (HCT), and antigen-specific adoptive T-cell therapy (ACT). We observed that Pim2 was critical for T cells to retain quiescent in aged mice, as thymic Treg development was impaired while effector T-cell differentiation in lymphoid organs, including Tc1/Th1, Tc17/Th17 and follicular helper T cells, was increased in Pim2-deficient mice, but not in Pim1/Pim3-deficient mice. Furthermore, Pim2-deficient mice were capable to completely eradicate syngeneic breast cancer (NT2.5) growth (Figure A). During antigen specific anti-tumor response, adoptively transferred Pim2 -/- CD8 T cells showed enhanced ability for controlling established NT2.5 breast cancer and B16 melanoma (Figure B, C). Mechanistically, loss of Pim2 promoted G1 to S phase cell-cycle progression while reduced apoptosis in CD8 T cells. Pim2 -/- CD8 T cells exhibited elevated effector cytokine production while maintained higher levels of CD62L expression, leading to superior effector function, persistence and anti-tumor activity. Reduced differentiation of exhausted and suppressive subsets were observed in Pim2 -/- CD8 T cells after being adoptively transferred in tumor-bearing mice. In addition, Pim2 deficiency was associated with a higher metabolic potential, reflected by increased glycolysis and oxidative phosphorylation, which was at least partially attributed to a decreased level of autophagy in Pim2 -/- CD8 T cells. To further evaluate the clinical translation potential, we applied a Pim2-specific inhibitor (JP11646) and found that blocking Pim2 improved graft-versus-leukemia activity after autologous HCT and also enhanced CD8 T-cell mediated anti-melanoma effects after ACT in mice (Figure B, C). Furthermore, blocking Pim2 using JP11646 promoted human CD8 T-cell response during polyclonal stimulation and enhanced expansion, effector function and tumor killing ability of human melanoma antigen-specific CD8 T cells (data not shown) and CD19 CAR-T cells (Figure D). Our work demonstrated that Pim2 is a potent and distinct regulator of differentiation and maintenance of T effector cells through modulating metabolism and autophagy. Specifically target Pim2 can serve as a novel strategy for improving cancer immunotherapy.

ANT2 (SLC25A5) balances the pro-apoptotic vs. effector signals of Bim in CD8 T cells

Dual function of Bim is switched by ANT2 (SLC25A5) to balance apoptotic and effective signals in CD8+ T cells

Bcl-2 Is Necessary to Counteract Bim and Promote Survival of TCRαβ+CD8αα+ Intraepithelial Lymphocyte Precursors in the Thymus

Bim, a Proapoptotic Protein, Up-regulated via Transcription Factor E2F1-dependent Mechanism, Functions as a Prosurvival Molecule in Cancer

Targeting Pim2 for Improving T-Cell Effector Function and Promoting Cancer Immunotherapy

Abstract 1727: Evidence That E2F1-mediated Upregulation of Bim, a Proapoptotic BH3-only Protein, Functions As a Prosurvival Molecule in Cancer.

APC(Cdc20) Suppresses Apoptosis Through Targeting Bim for Ubiquitination and Destruction.

The Major Isoforms of Bim Contribute to Distinct Biological Activities That Govern the Processes of Autophagy and Apoptosis in Interleukin-7 Dependent Lymphocytes.

Bim is Required for T-cell Allogeneic Responses and Graft-Versus-host Disease in Vivo.

Natural Diterpenoid Compound Elevates Expression of Bim Protein, Which Interacts with Antiapoptotic Protein Bcl-2, Converting It to Proapoptotic Bax-like Molecule

Pim2 Negatively Regulates T-cell Immune Responses Through Modulating Autophagy

Loss of BIM increases mitochondrial oxygen consumption and lipid oxidation, reduces adiposity and improves insulin sensitivity in mice

The association between BIM deletion polymorphism and treatment efficacy of PD-1/PD-L1 inhibitors in advanced NSCLC.

Interleukin-7 Regulates Bim Proapoptotic Activity in Peripheral T-Cell Survival

B-cell-specific checkpoint molecules that regulate anti-tumour immunity

Microenvironment-Mediated Bim Down-Regulation Through Induction of Microrna-181a Protects Cells from Apoptosis in Mantle-Cell and Other Non-Hodgkin B-Cell Lymphomas

The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics.

PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity.

Evidence That E2F1‐mediated Upregulation of Bim, a Proapoptotic BH3‐only Protein, Functions As a Prosurvival Molecule in Cancer

Mitochondrial C1QBP is essential for T cell antitumor function by maintaining mitochondrial plasticity and metabolic fitness

Combined loss of the BH3-only proteins Bim and Bmf restores B-cell development and function in TACI-Ig transgenic mice